CLINICAL_TRIALS
trial_result
· 2019-12-05
Clinical Trial Update: Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes. [Phase 4]
Summary
Phase 4 trial update assessing sacubitril/valsartan effects on biomarkers, myocardial remodeling, and outcomes in heart failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2019-12-05